Regulation of Canada

Blood Regulations

Statute Watch

Get an alert when a bill in Parliament would change this regulation, and every time it moves.

Citation
SOR/2013-178
Current to
July 24, 2025
Last amended
April 23, 2015
Made under
Food and Drugs Act, R.S.C. 1985, c. F-27
Official text
Justice Laws Website ↗

Bills in Parliament that would change it 1

  • S-252 Voluntary Blood Donations Act (An Act to amend the Blood Regulations) Amends s. 4 · 42nd Parliament, 1st session

Contents 129 entries

Interpretation

1 Definitions

Application

2 Scope of Regulations 3 Non-application — various therapeutic products

Prohibitions

4 Allogeneic blood

Authorizations, Establishment Licences and Registrations

Authorizations

5 Authorization — processing 6 Application for authorization 7 Issuance 8 Refusal 9 Significant changes 10 Emergency changes 11 Administrative changes — notice 12 Other changes — annual report 13 New or amended terms and conditions 14 Suspension 15 Reinstatement 16 Cancellation

Establishment Licences

17 Establishment licence required 18 Application for establishment licence 19 Inspection 20 Issuance 21 Refusal 22 Changes requiring application to amend licence 23 Administrative changes — notice 24 Changes requiring amendment of licence by Minister 25 New or amended terms and conditions 26 Additional information 27 Suspension 28 Reinstatement 29 Cancellation

Registration

30 Requirement to register 31 Application for registration 32 Registration 33 Changes — notice 34 Amendment by Minister 35 Annual statement of compliance 36 Additional information 37 Cancellation

Processing

Donor Suitability Assessment

38 Non-application — autologous donations 39 Licensed establishments 40 Past unsuitability 41 Donor screening 42 Exclusion criteria 43 When donor determined unsuitable 44 When donor determined suitable

Collection

45 Licensed establishments 46 Donor identification code 47 Donation code 48 Labelling of containers 49 Collection procedures 50 Samples 51 Autologous donations

Testing

52 Authorization 53 Autologous donations — transmissible disease testing 54 Autologous donations — ABO and Rh 55 Medical devices 56 Test results — allogeneic blood

Blood Component Preparation

57 Licensed establishments 58 Registered establishments

Labelling

59 Non-application — pre-assessed donors 60 Language requirement 61 General requirements 62 Circular of information 63 Donation code 64 Contents of label — blood for transfusion 65 Aliquots 66 Designated donations 67 Directed donations 68 Label verification

Storage

69 Criteria — collecting establishment 70 Storage location 71 Segregation — autologous, designated and directed donations 72 Segregation — untested or positive or reactive test results

Distribution

73 Determination of safety — allogeneic blood 74 Verification 75 Shipping containers 76 Storage during transportation

Transformation

77 Transformation methods 78 Washing 79 Pooling 80 Irradiation

Exceptional Distribution, Pre-Assessed Donor Programs and Importation in Urgent Circumstances

Exceptional Distribution

81 Conditions 82 Notice of exceptional distribution 83 Labelling 84 Follow-up 85 When blood not transfused

Pre-assessed Donor Programs

86 Program characteristics 87 Donor identification code 88 Regular donor assessment and testing 89 At each collection 90 Labelling 91 When blood not transfused

Importation in Urgent Circumstances

92 Information — before importation

Quality Management

Quality Management System

93 Organizational structure 94 Requirements

Operating Procedures

95 Operating procedures required 96 Requirements 97 Documented evidence

Personnel, Facilities, Equipment and Supplies

98 Personnel 99 Facilities 100 Equipment 101 Storage equipment 102 Supplies

Error and Accident Investigation and Reporting

Errors and Accidents

103 Error or accident of another establishment 104 Establishment’s own error or accident

Investigation and Reporting

105 Requirement to cooperate 106 Investigation results 107 Reports to Minister 108 Annual report

Adverse Reaction Investigation and Reporting

Adverse Donor Reactions

109 Notice to Minister

Adverse Recipient Reactions

110 Required action 111 Autologous donations

Investigation and Reporting of Adverse Recipient Reactions

112 Requirement to cooperate 113 Notice to Minister 114 Results of investigation 115 Final report to Minister 116 Annual report

Records

117 Record quality 118 Donation code part of all records 119 Retention periods — allogeneic blood 120 Retention periods — autologous blood 121 Retention periods — transformation 122 Retention periods — transfusion 123 Storage of records

Powers of Inspectors

124 Making visual recordings

Consequential Amendment

125 [Amendment]

Transitional Provisions

126 Deemed authorization 127 Licence continued 128 Delayed registration

Coming into Force

129 One year after publication